A combination of cis-platinum, doxorubicin (Adriamycin), and methotrexate was used to treat 28 patients with recurrent cervical cancer. Seven patients achieved a partial response with a median duration of ten months. Two patients achieved a complete response with a median duration of 14 months. The overall response rate was 32%. Ten patients with stable disease had a median progression-free interval of 4.5 months. Toxicity was acceptable.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
cis-platinum doxorubicin
8
recurrent cervical
8
cervical cancer
8
patients achieved
8
response median
8
median duration
8
doxorubicin methotrexate
4
methotrexate treatment
4
treatment recurrent
4
cancer combination
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!